Working…
ClinicalTrials.gov
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

Key Record Dates

ClinicalTrials.gov Identifier: NCT02751918
Brief Title: Phase Ib Study of Anetumab Ravtansine in Combination With Pegylated Liposomal Doxorubicin in Patients With Recurrent Mesothelin-expressing Platinum-resistant Cancer

First Submitted : April 22, 2016
First Submitted that Met QC Criteria : April 22, 2016
First Posted : April 26, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : November 21, 2019
Last Update Posted : November 22, 2019